RP
Rimi Paul
About Rimi Paul
Data last updated:
Rimi Paul is a Director at Criceto Pharmaceuticals Private Limited (since 2021). The company operates in Pharma. Criceto Pharmaceuticals Private Limited reported revenue of ₹1.36 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Criceto Pharmaceuticals Private Limited U24290AS2021PTC021111 | Director | 10 Mar 2021 | 2021 | ₹1.36 Cr (FY 2025) | Active |
Board colleagues of Rimi Paul
| Name | DIN | Company | Designation |
|---|---|---|---|
| Chandrima Banerjee | 09100088 | Criceto Pharmaceuticals Private Limited | Director |
| Jaydip Bhowmick | 10235269 | Criceto Pharmaceuticals Private Limited | Director |
| Subrata Banerjee | 10234849 | Criceto Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rimi Paul
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rimi Paul
Rimi Paul currently holds 1 directorship: Criceto Pharmaceuticals Private Limited (Director, since 10 Mar 2021, revenue ₹1.36 Cr (FY 2025)).
Rimi Paul was first appointed on 10 Mar 2021 as Director at Criceto Pharmaceuticals Private Limited.
The current boards of Rimi Paul's companies include Chandrima Banerjee (Criceto Pharmaceuticals Private Limited), Jaydip Bhowmick (Criceto Pharmaceuticals Private Limited), Subrata Banerjee (Criceto Pharmaceuticals Private Limited).